Literature DB >> 19276457

Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk.

Steven R Cummings1, Jeffrey A Tice, Scott Bauer, Warren S Browner, Jack Cuzick, Elad Ziv, Victor Vogel, John Shepherd, Celine Vachon, Rebecca Smith-Bindman, Karla Kerlikowske.   

Abstract

BACKGROUND: It is uncertain whether evidence supports routinely estimating a postmenopausal woman's risk of breast cancer and intervening to reduce risk.
METHODS: We systematically reviewed prospective studies about models and sex hormone levels to assess breast cancer risk and used meta-analysis with random effects models to summarize the predictive accuracy of breast density. We also reviewed prospective studies of the effects of exercise, weight management, healthy diet, moderate alcohol consumption, and fruit and vegetable intake on breast cancer risk, and used random effects models for a meta-analyses of tamoxifen and raloxifene for primary prevention of breast cancer. All studies reviewed were published before June 2008, and all statistical tests were two-sided.
RESULTS: Risk models that are based on demographic characteristics and medical history had modest discriminatory accuracy for estimating breast cancer risk (c-statistics range = 0.58-0.63). Breast density was strongly associated with breast cancer (relative risk [RR] = 4.03, 95% confidence interval [CI] = 3.10 to 5.26, for Breast Imaging Reporting and Data System category IV vs category I; RR = 4.20, 95% CI = 3.61 to 4.89, for >75% vs <5% of dense area), and adding breast density to models improved discriminatory accuracy (c-statistics range = 0.63-0.66). Estradiol was also associated with breast cancer (RR range = 2.0-2.9, comparing the highest vs lowest quintile of estradiol, P < .01). Most studies found that exercise, weight reduction, low-fat diet, and reduced alcohol intake were associated with a decreased risk of breast cancer. Tamoxifen and raloxifene reduced the risk of estrogen receptor-positive invasive breast cancer and invasive breast cancer overall.
CONCLUSIONS: Evidence from this study supports screening for breast cancer risk in all postmenopausal women by use of risk factors and breast density and considering chemoprevention for those found to be at high risk. Several lifestyle changes with the potential to prevent breast cancer should be recommended regardless of risk.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19276457      PMCID: PMC2720698          DOI: 10.1093/jnci/djp018

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  102 in total

1.  Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

Authors:  Victor G Vogel; Joseph P Costantino; D Lawrence Wickerham; Walter M Cronin; Reena S Cecchini; James N Atkins; Therese B Bevers; Louis Fehrenbacher; Eduardo R Pajon; James L Wade; André Robidoux; Richard G Margolese; Joan James; Scott M Lippman; Carolyn D Runowicz; Patricia A Ganz; Steven E Reis; Worta McCaskill-Stevens; Leslie G Ford; V Craig Jordan; Norman Wolmark
Journal:  JAMA       Date:  2006-06-05       Impact factor: 56.272

2.  Breast cancer risk reduction options: awareness, discussion, and use among women from four ethnic groups.

Authors:  Celia Patricia Kaplan; Jennifer S Haas; Eliseo J Pérez-Stable; Steven E Gregorich; Carol Somkin; Genevieve Des Jarlais; Karla Kerlikowske
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-01       Impact factor: 4.254

3.  Adult weight change and risk of postmenopausal breast cancer.

Authors:  A Heather Eliassen; Graham A Colditz; Bernard Rosner; Walter C Willett; Susan E Hankinson
Journal:  JAMA       Date:  2006-07-12       Impact factor: 56.272

4.  Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women.

Authors:  Elizabeth Barrett-Connor; Lori Mosca; Peter Collins; Mary Jane Geiger; Deborah Grady; Marcel Kornitzer; Michelle A McNabb; Nanette K Wenger
Journal:  N Engl J Med       Date:  2006-07-13       Impact factor: 91.245

5.  Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis.

Authors:  Valerie A McCormack; Isabel dos Santos Silva
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-06       Impact factor: 4.254

6.  Meta-analysis of studies of alcohol and breast cancer with consideration of the methodological issues.

Authors:  Jane Key; Susan Hodgson; Rumana Z Omar; Tina K Jensen; Simon G Thompson; Alan R Boobis; Donald S Davies; Paul Elliott
Journal:  Cancer Causes Control       Date:  2006-08       Impact factor: 2.506

7.  Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Authors:  Rachael Z Stolzenberg-Solomon; Shih-Chen Chang; Michael F Leitzmann; Karen A Johnson; Christine Johnson; Saundra S Buys; Robert N Hoover; Regina G Ziegler
Journal:  Am J Clin Nutr       Date:  2006-04       Impact factor: 7.045

8.  Breast cancer risk assessment in the Czech female population--an adjustment of the original Gail model.

Authors:  Jan Novotny; Ladislav Pecen; Lubos Petruzelka; Adam Svobodnik; Ladislav Dusek; Jan Danes; Miloslava Skovajsova
Journal:  Breast Cancer Res Treat       Date:  2005-12-01       Impact factor: 4.872

9.  Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial.

Authors:  Ross L Prentice; Bette Caan; Rowan T Chlebowski; Ruth Patterson; Lewis H Kuller; Judith K Ockene; Karen L Margolis; Marian C Limacher; JoAnn E Manson; Linda M Parker; Electra Paskett; Lawrence Phillips; John Robbins; Jacques E Rossouw; Gloria E Sarto; James M Shikany; Marcia L Stefanick; Cynthia A Thomson; Linda Van Horn; Mara Z Vitolins; Jean Wactawski-Wende; Robert B Wallace; Sylvia Wassertheil-Smoller; Evelyn Whitlock; Katsuhiko Yano; Lucile Adams-Campbell; Garnet L Anderson; Annlouise R Assaf; Shirley A A Beresford; Henry R Black; Robert L Brunner; Robert G Brzyski; Leslie Ford; Margery Gass; Jennifer Hays; David Heber; Gerardo Heiss; Susan L Hendrix; Judith Hsia; F Allan Hubbell; Rebecca D Jackson; Karen C Johnson; Jane Morley Kotchen; Andrea Z LaCroix; Dorothy S Lane; Robert D Langer; Norman L Lasser; Maureen M Henderson
Journal:  JAMA       Date:  2006-02-08       Impact factor: 56.272

10.  The association of mammographic density with ductal carcinoma in situ of the breast: the Multiethnic Cohort.

Authors:  Jasmeet K Gill; Gertraud Maskarinec; Ian Pagano; Laurence N Kolonel
Journal:  Breast Cancer Res       Date:  2006-06-23       Impact factor: 6.466

View more
  95 in total

1.  AGO Recommendations for Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Update 2011.

Authors:  Christoph Thomssen; Anton Scharl; Nadia Harbeck
Journal:  Breast Care (Basel)       Date:  2011-08-30       Impact factor: 2.860

2.  A novel automated mammographic density measure and breast cancer risk.

Authors:  John J Heine; Christopher G Scott; Thomas A Sellers; Kathleen R Brandt; Daniel J Serie; Fang-Fang Wu; Marilyn J Morton; Beth A Schueler; Fergus J Couch; Janet E Olson; V Shane Pankratz; Celine M Vachon
Journal:  J Natl Cancer Inst       Date:  2012-07-03       Impact factor: 13.506

3.  Lobular involution, mammographic density, and breast cancer risk: visualizing the future?

Authors:  Gretchen L Gierach; Louise A Brinton; Mark E Sherman
Journal:  J Natl Cancer Inst       Date:  2010-10-29       Impact factor: 13.506

4.  CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissues.

Authors:  Rosa Anna DeFilippis; Hang Chang; Nancy Dumont; Joseph T Rabban; Yunn-Yi Chen; Gerald V Fontenay; Hal K Berman; Mona L Gauthier; Jianxin Zhao; Donglei Hu; James J Marx; Judy A Tjoe; Elad Ziv; Maria Febbraio; Karla Kerlikowske; Bahram Parvin; Thea D Tlsty
Journal:  Cancer Discov       Date:  2012-07-09       Impact factor: 39.397

5.  The Impact of Nutrition on the Development and Prognosis of Breast Cancer.

Authors:  Hans Hauner; Dagmar Hauner
Journal:  Breast Care (Basel)       Date:  2010-12-08       Impact factor: 2.860

6.  Sex hormone levels and risk of breast cancer with estrogen plus progestin.

Authors:  Ghada N Farhat; Neeta Parimi; Rowan T Chlebowski; Joann E Manson; Garnet Anderson; Alison J Huang; Eric Vittinghoff; Jennifer S Lee; Andrea Z Lacroix; Jane A Cauley; Rebecca Jackson; Deborah Grady; Dorothy S Lane; Lawrence Phillips; Michael S Simon; Steven R Cummings
Journal:  J Natl Cancer Inst       Date:  2013-09-16       Impact factor: 13.506

7.  Effect of aerobic exercise on tumor physiology in an animal model of human breast cancer.

Authors:  Lee W Jones; Benjamin L Viglianti; Jessica A Tashjian; Sejal M Kothadia; Stephen T Keir; Stephen J Freedland; Michael Q Potter; Eui Jung Moon; Thies Schroeder; James E Herndon; Mark W Dewhirst
Journal:  J Appl Physiol (1985)       Date:  2009-12-03

8.  Breast cancer risk prediction using a clinical risk model and polygenic risk score.

Authors:  Yiwey Shieh; Donglei Hu; Lin Ma; Scott Huntsman; Charlotte C Gard; Jessica W T Leung; Jeffrey A Tice; Celine M Vachon; Steven R Cummings; Karla Kerlikowske; Elad Ziv
Journal:  Breast Cancer Res Treat       Date:  2016-08-26       Impact factor: 4.872

9.  Assessing breast cancer risk models in Marin County, a population with high rates of delayed childbirth.

Authors:  Mark Powell; Farid Jamshidian; Kate Cheyne; Joanne Nititham; Lee Ann Prebil; Rochelle Ereman
Journal:  Clin Breast Cancer       Date:  2013-11-22       Impact factor: 3.225

10.  Baseline mammographic breast density and the risk of invasive breast cancer in postmenopausal women participating in the NSABP study of tamoxifen and raloxifene (STAR).

Authors:  Reena S Cecchini; Joseph P Costantino; Jane A Cauley; Walter M Cronin; D Lawrence Wickerham; Hanna Bandos; Joel L Weissfeld; Norman Wolmark
Journal:  Cancer Prev Res (Phila)       Date:  2012-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.